By Abigail W. Adams
Portland, Me., June 15 – Achieve Life Sciences priced $9.16 million, or 9,158 class B units after the market close on Friday at par with each unit consisting of 1 share of series A convertible preferred stock and warrants.
The class B units priced alongside $2.84 million, or 710,500 class A units consisting of one share of common stock and a warrant to purchase 1 share of common stock at a public offering price of $4 per unit.
Ladenburg Thalmann is bookrunner for the registered offering, which carries a greenshoe of up to 450,000 shares of common stock and warrants to purchase up to 450,000 shares of common stock.
The class B units were offered to purchasers whose participation in the class A units offering would result in the beneficial ownership of more than 4.99% of outstanding common stock.
The series A preferred stock is convertible into 250 shares of common stock. The warrants in each class B unit are exercisable for 250 shares of common stock at a strike price of $4.
The warrants expire five years from the issue date.
Net proceeds from the offerings are expected to be $10.6 million. Proceeds will be used to fund the development of cytisine, the company’s smoking cessation product candidate, and for general corporate purposes.
Achieve Life Sciences is a Seattle, Wa.-based specialty pharmaceutical company focusing on smoking cessation products.
Issuer: | Achieve Life Sciences
|
Bookrunners: | Ladenburg Thalmann
|
Greenshoe: | 450,000 shares of common stock and warrants to purchase up to 450,000 shares of common stock
|
Maturity: | 2023
|
Stock symbol: | Nasdaq: ACHV
|
Stock price: | $3.65 at the market close June 15
|
Market capitalization: | $471,138
|
|
Class B Units
|
Securities: | Class B units consisting of 1 share of series A convertible preferred stock and warrants for 250 common shares
|
Amount: | $9.16 million, or 9,158 units
|
Coupon: | 0%
|
Price: | Par
|
Conversion price: | $4.00
|
Conversion rate: | 250
|
Pricing date: | June 15
|
|
Class A Units
|
Securities: | Class A units consisting of 1 share of common stock and warrants to purchase 1 share of common stock
|
Amount: | $2.84 million, or 710,500 units
|
Price: | $4.00
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.